Alterome Therapeutics logo

Alterome Therapeutics Funding & Investors

Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers.

alterome.com

Total Amount Raised: $231,000,000

Alterome Therapeutics Funding Rounds

  • Series B

    $132,000,000

    Series B Investors

    Goldman Sachs
    OrbiMed Advisors
    Canaan
    Nextech Invest
    Blue Owl
    Vida Ventures
    Invus
    Digitalis Ventures
    Colt Ventures
    Boxer Capital
    Driehaus Capital Management
  • Series A

    $35,000,000

    Series A Investors

    Colt Ventures
    OrbiMed Advisors
    Boxer Capital
    Nextech Invest
    Vida Ventures
  • Series A

    $64,000,000

    Series A Investors

    OrbiMed Advisors
    Vida Ventures
    Nextech Invest
    Boxer Capital
Funding info provided by Diffbot.